Journal of Clinical Oncology 临床肿瘤· Wentao Tang·· 2026-10-16AI 评分22
回复:关于直肠癌双检查点阻断及新辅助免疫治疗争议的评论
Reply to: “Is Dual-Checkpoint Blockade Beneficial Beyond Prolonging Chemoradiotherapy-to-Surgery Interval in Rectal Cancer?” and “Dual Immunotherapy in the Neoadjuvant Interval for Locally Advanced Rectal Cancer: A New Hope?”
AI 导读
该文章发表于 Journal of Clinical Oncology,针对直肠癌双免疫检查点阻断疗效及新辅助阶段应用的争议进行回复。
来源:Journal of Clinical Oncology 临床肿瘤 · ascopubs.org